Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Hirota

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 1, 2016
Epigenetic regulation of drug transporter expression in human tissuesTakeshi Hirota, Toshihiro Tanaka, Hiroaki Takesue, et al.
BMC Cancer|August 7, 2013
MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cellsKeisuke Gotanda, Takeshi Hirota, Nozomi Matsumoto, et al.
Oncogene|February 3, 2005
Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathwayTakeshi Hirota, Kenji Irie, Ryoko Okamoto, et al.
Journal of Neurochemistry|October 9, 2018
Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathyShunsuke Fujita, Takeshi Hirota, Ryo Sakiyama, et al.
British Journal of Clinical Pharmacology|March 26, 2022
Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child-Pugh and MELD scoresYasuo Kurata, Shota Muraki, Takeshi Hirota, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
Interindividual differences in placental expression of the SLC22A2 (OCT2) gene: relationship to epigenetic variations in the 5'-upstream regulatory regionJumpei Saito, Takeshi Hirota, Naomi Kikunaga, et al.
JCO Oncology Practice|June 10, 2025
Comprehensive Analysis of Detection Triggers for Immune-Related Adverse Events: Implications for Patient Education and ManagementHaruna Minami, Ryosuke Matsukane, Sai Yasukochi, et al.
Cureus|February 19, 2024
A Case Report of Drug Interactions Between Nirmatrelvir/Ritonavir and Tacrolimus in a Patient With Systemic Lupus ErythematosusNanae Yamamoto, Yuichi Tsuchiya, Mio Fukuda, et al.
Drug Metabolism and Pharmacokinetics|October 7, 2021
Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic studyYasuo Kurata, Shota Muraki, Takeshi Hirota, et al.
Clinical Pharmacokinetics|July 16, 2024
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell TransplantationKimitaka Suetsugu, Tomohiro Shigematsu, Takahiro Nakamura, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Expert Opinion on Drug Metabolism & Toxicology|September 1, 2016
Epigenetic regulation of drug transporter expression in human tissuesTakeshi Hirota, Toshihiro Tanaka, Hiroaki Takesue, et al.
BMC Cancer|August 7, 2013
MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cellsKeisuke Gotanda, Takeshi Hirota, Nozomi Matsumoto, et al.
Oncogene|February 3, 2005
Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathwayTakeshi Hirota, Kenji Irie, Ryoko Okamoto, et al.
Journal of Neurochemistry|October 9, 2018
Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathyShunsuke Fujita, Takeshi Hirota, Ryo Sakiyama, et al.
British Journal of Clinical Pharmacology|March 26, 2022
Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child-Pugh and MELD scoresYasuo Kurata, Shota Muraki, Takeshi Hirota, et al.
Journal of Pharmaceutical Sciences|April 28, 2011
Interindividual differences in placental expression of the SLC22A2 (OCT2) gene: relationship to epigenetic variations in the 5'-upstream regulatory regionJumpei Saito, Takeshi Hirota, Naomi Kikunaga, et al.
JCO Oncology Practice|June 10, 2025
Comprehensive Analysis of Detection Triggers for Immune-Related Adverse Events: Implications for Patient Education and ManagementHaruna Minami, Ryosuke Matsukane, Sai Yasukochi, et al.
Cureus|February 19, 2024
A Case Report of Drug Interactions Between Nirmatrelvir/Ritonavir and Tacrolimus in a Patient With Systemic Lupus ErythematosusNanae Yamamoto, Yuichi Tsuchiya, Mio Fukuda, et al.
Drug Metabolism and Pharmacokinetics|October 7, 2021
Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic studyYasuo Kurata, Shota Muraki, Takeshi Hirota, et al.
Clinical Pharmacokinetics|July 16, 2024
Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell TransplantationKimitaka Suetsugu, Tomohiro Shigematsu, Takahiro Nakamura, et al.
Pageof 9